Efficacy of oseltamivir treatment in influenza virus-infected obese mice

Efficacy of oseltamivir treatment in influenza virus-infected obese mice

ABSTRACT Obesity has been epidemiologically and empirically linked with more severe diseases upon influenza infection. To ameliorate severe disease, treatment with antivirals, such as the neuraminidase inhibitor oseltamivir, is suggested to begin within days of infection especially in high-risk host...

Full description

Bibliographic Details
Main Authors: Rebekah Honce, Jeremy Jones, Victoria A. Meliopoulos, Brandi Livingston, Bridgett Sharp, Leonardo D. Estrada, Lindsey Wang, William Caulfield, Burgess Freeman, Elena Govorkova, Stacey Schultz-Cherry
Format: Article
Language:English
Published: American Society for Microbiology 2023-08-01
Series:mBio
Subjects:
influenza
obesity
antiviral agents
efficacy
viral diversity
interferons
Online Access:https://journals.asm.org/doi/10.1128/mbio.00887-23

Internet

https://journals.asm.org/doi/10.1128/mbio.00887-23

Similar Items